ENANTA PHARMACEUTICALS INC (ENTA)
1 Item 5.02 filing since 2026-10-28 · roles: CEO. Nasdaq. Pharmaceutical Preparations. State: MA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-28 | Retirement announced | CEO | subscribers | — | ENANTA PHARMACEUTICALS INC (ENTA): CEO Jay R. Luly, Ph.D. to retire |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works